Related Experiment Video
Updated: Sep 3, 2025
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma
Massimiliano Cadamuro1, Adriana Romanzi2,3, Maria Guido4,5
1Department of Molecular Medicine (DMM), University of Padua, 35122 Padua, Italy.
Abstract:
The prognosis of cholangiocarcinoma remains poor in spite of the advances in immunotherapy and molecular profiling, which has led to the identification of several targetable genetic alterations. Surgical procedures, including both liver resection and liver transplantation, still represent the treatment with the best curative potential, though the outcomes are significantly compromised by the early development of lymph node metastases. Progression of lymphatic metastasis from the primary tumor to tumor-draining lymph nodes is mediated by tumor-associated lymphangiogenesis, a topic largely overlooked until recently. Recent findings highlight tumor-associated lymphangiogenesis as paradigmatic of the role played by the tumor microenvironment in sustaining cholangiocarcinoma invasiveness and progression. This study reviews the current knowledge about the intercellular signaling and molecular mechanism of tumor-associated lymphangiogenesis in cholangiocarcinoma in the hope of identifying novel therapeutic targets to halt a process that often limits the success of the few available treatments.
Insights
Cholangiocarcinoma (bile duct cancer) has a poor prognosis, often worsened by lymph node metastasis. This review explores tumor-associated lymphangiogenesis as a key driver of metastasis, aiming to identify new therapeutic targets.
Area of Science:
- Oncology
- Cancer Biology
- Translational Research
Background:
- Cholangiocarcinoma (CCA) prognosis remains poor despite advances in immunotherapy and targeted therapies.
- Lymph node metastasis significantly compromises surgical outcomes for CCA, limiting curative potential.
- Tumor-associated lymphangiogenesis is increasingly recognized as a critical factor in CCA progression.
Purpose of the Study:
- To review current knowledge on the mechanisms of tumor-associated lymphangiogenesis in cholangiocarcinoma.
- To identify intercellular signaling pathways and molecular mechanisms driving lymphangiogenesis in CCA.
- To highlight potential novel therapeutic targets for halting lymph node metastasis in CCA.
Main Methods:
- Literature review of recent findings on tumor-associated lymphangiogenesis in cholangiocarcinoma.
- Analysis of intercellular signaling and molecular mechanisms involved in lymphangiogenesis.
- Synthesis of information to identify therapeutic targets.
Main Results:
- Tumor-associated lymphangiogenesis is a key process in cholangiocarcinoma metastasis.
- The tumor microenvironment plays a crucial role in sustaining CCA invasiveness via lymphangiogenesis.
- Understanding these mechanisms is vital for developing new treatment strategies.
Conclusions:
- Targeting tumor-associated lymphangiogenesis presents a promising strategy to improve cholangiocarcinoma treatment outcomes.
- Further research into the molecular drivers of lymphangiogenesis in CCA is warranted.
- Identifying novel therapeutic targets could overcome limitations of current treatments for bile duct cancer.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...